ATNAA atropine and pralidoxime chlorideAuto-Injector (Meridian Medical Technologies, Inc.)
Welcome to the PulseAid listing for the ATNAA atropine and pralidoxime chloride drug offered from Meridian Medical Technologies, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Meridian Medical Technologies, Inc. |
NON-PROPRIETARY NAME: | atropine and pralidoxime chloride |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-01-17 |
END MARKETING DATE: | 0000-00-00 |
ATNAA atropine and pralidoxime chloride Auto-Injector HUMAN PRESCRIPTION DRUG Details:
Item Description | ATNAA atropine and pralidoxime chloride Auto-Injector from Meridian Medical Technologies, Inc. |
LABELER NAME: | Meridian Medical Technologies, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2002-01-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 11704-777_755922b7-5fd0-4d8c-9f4f-75dc63f295c2 |
PRODUCT NDC: | 11704-777 |
APPLICATION NUMBER: | NDA021175 |